Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.

@article{Hasimu2007EvaluationOM,
  title={Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.},
  author={Buaijiaer Hasimu and Jue Kun Li and Jinming Yu and Yi-Tong Ma and Mingzhong Zhao and Tomohiro Nakayama and Wenlin Ma and Jingang Yang and Liqiang Zheng and Xiankai Li and Yingyi Luo and Yuanxi Xu and Lihua Zhang and Lilin Zou and Weilin Xiao and Yalei Han and Da-yi Hu},
  journal={Circulation journal : official journal of the Japanese Circulation Society},
  year={2007},
  volume={71 1},
  pages={95-9}
}
BACKGROUND Peripheral arterial disease (PAD) is an important manifestation of systemic atherosclerosis and is associated with elevated cardiovascular morbidity and mortality. The aim of the present study was to evaluate the use of antiplatelet agents, statins and angiotensin-converting enzyme inhibitors (ACEI) in Chinese high-risk cardiovascular (CV… CONTINUE READING